Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Copper-Photocatalyzed Borylation of Organic Halides under Batch and Continuous-Flow Conditions.

Nitelet A, Thevenet D, Schiavi B, Hardouin C, Fournier J, Tamion R, Pannecoucke X, Jubault P, Poisson T.

Chemistry. 2019 Mar 1;25(13):3262-3266. doi: 10.1002/chem.201806345. Epub 2019 Feb 6.

PMID:
30600852
2.

[Infections of implantable ports in haematology patients].

Bugeaud J, Colombat P, Vallet N, Hardouin C, Thibault N.

Rev Infirm. 2017 Aug - Sep;66(233):41-43. doi: 10.1016/j.revinf.2017.06.011. French.

PMID:
28865699
3.

Structure-activity relationships of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.

Hardouin C, Kelso MJ, Romero FA, Rayl TJ, Leung D, Hwang I, Cravatt BF, Boger DL.

J Med Chem. 2007 Jul 12;50(14):3359-68. Epub 2007 Jun 9.

4.

Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics.

Boger DL, Miyauchi H, Du W, Hardouin C, Fecik RA, Cheng H, Hwang I, Hedrick MP, Leung D, Acevedo O, GuimarĂ£es CR, Jorgensen WL, Cravatt BF.

J Med Chem. 2005 Mar 24;48(6):1849-56.

6.

Heterocyclic sulfoxide and sulfone inhibitors of fatty acid amide hydrolase.

Du W, Hardouin C, Cheng H, Hwang I, Boger DL.

Bioorg Med Chem Lett. 2005 Jan 3;15(1):103-6.

PMID:
15582420
7.

Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity.

Lichtman AH, Leung D, Shelton CC, Saghatelian A, Hardouin C, Boger DL, Cravatt BF.

J Pharmacol Exp Ther. 2004 Nov;311(2):441-8. Epub 2004 Jun 30.

PMID:
15229230
8.

Fundamental role of the fostriecin unsaturated lactone and implications for selective protein phosphatase inhibition.

Buck SB, Hardouin C, Ichikawa S, Soenen DR, Gauss CM, Hwang I, Swingle MR, Bonness KM, Honkanen RE, Boger DL.

J Am Chem Soc. 2003 Dec 24;125(51):15694-5.

PMID:
14677930
9.

Discovering potent and selective reversible inhibitors of enzymes in complex proteomes.

Leung D, Hardouin C, Boger DL, Cravatt BF.

Nat Biotechnol. 2003 Jun;21(6):687-91. Epub 2003 May 12.

PMID:
12740587
10.

Selective deoxygenation of leurosine: concise access to anhydrovinblastine.

Hardouin C, Doris E, Rousseau B, Mioskowski C.

J Org Chem. 2002 Sep 6;67(18):6571-4.

PMID:
12201787
11.

Concise synthesis of anhydrovinblastine from leurosine.

Hardouin C, Doris E, Rousseau B, Mioskowski C.

Org Lett. 2002 Apr 4;4(7):1151-3.

PMID:
11922805
12.

Cp2TiCl-mediated selective reduction of alpha,beta-epoxy ketones.

Hardouin C, Chevallier F, Rousseau B, Doris E.

J Org Chem. 2001 Feb 9;66(3):1046-8. No abstract available.

PMID:
11430072
13.

BF3*OET2-mediated rearrangement of cyclopropyl carbinols: a concise route to polycyclic cyclobutanes.

Hardouin C, Taran F, Doris E.

J Org Chem. 2001 Jun 15;66(12):4450-2. No abstract available.

PMID:
11397196
14.

Leurosine methiodide-methanol-water (1/3/2).

Hardouin C, Doris E, Rousseau B, Mioskowski C, Nierlich M.

Acta Crystallogr C. 2000 Feb;56 ( Pt 2):225-6. No abstract available.

PMID:
10777895
15.

Prevention of early postmenopausal bone loss with cyclical etidronate therapy (a double-blind, placebo-controlled study and 1-year follow-up)

Meunier PJ, Confavreux E, Tupinon I, Hardouin C, Delmas PD, Balena R.

J Clin Endocrinol Metab. 1997 Sep;82(9):2784-91. Erratum in: J Clin Endocrinol Metab 1997 Nov;82(11):3740.

PMID:
9284696
16.

Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study.

Delmas PD, Balena R, Confravreux E, Hardouin C, Hardy P, Bremond A.

J Clin Oncol. 1997 Mar;15(3):955-62.

PMID:
9060533
17.

Bone mineral density of the hip measured with dual-energy X-ray absorptiometry in normal elderly women and in patients with hip fracture.

Duboeuf F, Braillon P, Chapuy MC, Haond P, Hardouin C, Meary MF, Delmas PD, Meunier PJ.

Osteoporos Int. 1991 Sep;1(4):242-9.

PMID:
1790411

Supplemental Content

Loading ...
Support Center